Clin2
NCT07340775Worth exploringNot yet recruiting

Amylin sensitivity in post-traumatic headache

Headache Disorders, SecondaryBrain DiseasesHeadache DisordersNervous System DiseasesCentral Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This study checks if a natural substance called amylin might make your headache worse after a head injury. The researchers will see how your body reacts to amylin compared to a placebo, which could help find new treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
21 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have had a persistent headache for at least 12 months that started after a mild head injury (like a concussion).
  • You have headaches on at least 4 days each month, on average, over the last 3 months.
  • You had no frequent headaches or migraines before your head injury (only occasional tension headaches are okay).
  • You have had no more than one mild head injury, and no moderate or severe head injury, whiplash, or skull surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07340788Not yet recruiting
Testing a migraine trigger for people without aura

This study looks at whether a natural substance called amylin can trigger migraine attacks in people who get migraines without aura. If you join, you'll receive an infusion and be monitored to see if you get a migraine, which could help researchers understand migraine causes.

Glostrup Municipality
NCT07451769Recruiting
Testing a new drug target for migraine relief

This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.

Glostrup Municipality
NCT07191145Not yet recruiting· Phase 3
Early eptinezumab infusions for post-traumatic headaches

This trial tests whether giving eptinezumab (an antibody that blocks a pain protein) soon after a head injury can reduce the severity and duration of headaches that start after trauma. If you've had new or worsening headaches within the past 8 weeks after a head injury, this treatment might help prevent them from becoming chronic.

Toronto, Ontario
NCT07229391Not yet recruiting
Behavior therapy vs education for headaches after head injury

This study compares two non-drug treatments for people with persistent headaches that started or worsened after a mild head injury (concussion). One treatment is behavior therapy, which teaches skills to manage pain, and the other is education about headaches. The goal is to see which approach helps more.

San Diego, California
NCT07059546Recruiting
Studying sensitivity to adrenomedullin in chronic post-traumatic headache

This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.

Glostrup Municipality
NCT06839118Recruiting· Phase 3
Botox for headaches after head injury

This trial tests if Botox injections can reduce headache days in people with persistent headaches after a mild head injury. It may help if you have headaches at least 15 days a month.

Glostrup Municipality

Hear when a new Headache Disorders, Secondary trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.